ARCHIVES

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

New CCOP RFA To Encourage Cancer Control Research; Larger But Fewer Awards Are Likely

May 9, 1986

Raub Corrects Record on ALERT

April 20, 1984

Boston Study Finds Adenocarcinoma Of Esophagus Increasing

July 14, 1989

House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI

August 7, 1992

President’s Cancer Panel Urges Greater Emphasis On Prevention.

September 21, 2007